OTTAWA, Ontario--(BUSINESS WIRE)--Mar 23, 2026--
Kinaxis ® Inc. (TSX: KXS), a global leader in supply chain orchestration, today announced it has been positioned as a Leader in both the 2026 Gartner ® Magic Quadrant™ for Supply Chain Planning Solutions for Discrete Industries and the 2026 Gartner ® Magic Quadrant™ for Supply Chain Planning Solutions for Process Industries. In both reports, Gartner recognized Kinaxis for its ability to execute and completeness of vision.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260323129357/en/
Kinaxis has been recognized as a Leader in the Gartner ® Magic Quadrant™ for Supply Chain Planning Solutions for eleven times in a row. Kinaxis has also been recognized as a Leader in the 2026 Gartner Magic Quadrant for Supply Chain Planning Solutions for Process Industries and Discrete Industries.
“In our opinion, being named a Leader reflects the growing need for supply chains to deliver measurable business outcomes in the face of constant disruption,” said Andrew Bell, Chief Product Officer at Kinaxis. “Organizations today must maintain and improve service levels, optimize working capital, and respond to volatility in real time. Maestro unifies planning and execution in a concurrent environment where automation and AI help teams act with speed and confidence, driving adaptability that sustains performance.”
As supply chains increasingly operate continuously rather than in fixed planning cycles, organizations require orchestration that keeps pace with constant change. Kinaxis delivers this through Maestro™, its AI-powered platform spanning S&OP, demand, supply, inventory, production planning and scheduling. By combining deterministic automation and composable agentic AI in a shared concurrent model, Maestro enables confident decision-making at enterprise scale across organizations from the mid-market to global enterprises.
With expanded Maestro Agents, Maestro Agent Studio, and a unified data foundation, Kinaxis supports both repeatable execution and adaptive reasoning within a governed environment. These advancements are supported by strategic partnerships including Databricks and with other leading software vendors in the broader enterprise ecosystem. Innovation is further reinforced by Kinaxis’ expanding intellectual property portfolio, which includes nearly 90 issued patents globally and a significant number of additional patents pending across multiple jurisdictions. Approximately 45% of the portfolio focuses on AI and machine learning, underscoring continued investment in intelligent supply chain orchestration.
Complimentary copies of the 2026 Gartner ® Magic Quadrant™ for Supply Chain Planning Solutions for Discrete Industries and for Process Industries reports are available for download here.
Gartner Disclaimer:
Note:
1 Gartner, 2026 Magic Quadrant for Supply Chain Planning Solutions for Process Industries
Gartner, 2026 Magic Quadrant for Supply Chain Planning Solutions for Discrete Industries
Gartner, Magic Quadrant for Supply Chain Planning Solutions – 2021, 2022, 2023, 2024, 2025
Gartner, Magic Quadrant for Supply Chain Planning System of Record – 2014, 2016, 2018
Gartner, Magic Quadrant for Sales and Operations Planning Systems of Differentiation – 2019, 2017, 2015
Gartner does not endorse any company, vendor, product or service depicted in its publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner publications consist of the opinions of Gartner’s business and technology insights organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this publication, including any warranties of merchantability or fitness for a particular purpose.
Gartner and Magic Quadrant are a trademark of Gartner, Inc., and/or its affiliates.
About Kinaxis
Kinaxis is a leader in modern supply chain orchestration, powering complex global supply chains, and supporting the people who manage them. Our powerful, AI-infused supply chain orchestration platform, Maestro, combines proprietary technologies and techniques that provide full transparency and agility across the entire supply chain — from multi-year strategic planning to last-mile delivery. We are trusted by renowned global brands to provide the agility and predictability needed to navigate today’s volatility and disruption. For more news and information, please visit kinaxis.com or follow us on LinkedIn.
Source: Kinaxis Inc.
Kinaxis Recognized as a Leader in the 2026 Gartner® Magic Quadrant™ Reports for Supply Chain Planning: Discrete Industries
NEW YORK (AP) — Luigi Mangione’s guilty plea on Friday to federal stalking-to-kill charges raised immediate questions about why he decided to enter that plea, how it’ll affect his parallel state murder case and what his lawyers might do to prevent Mangione from spending the rest of his life in prison.
In a stunning turn, Mangione pleaded guilty in Manhattan federal court to a pair of stalking charges and admitted that he targeted and killed UnitedHealthcare CEO Brian Thompson as the executive walked to his company’s investor conference at a Manhattan hotel in 2024.
Neither Mangione nor his lawyers said why he pleaded guilty now, but they gave some clues.
Immediately after his plea, Mangione’s lawyers filed paperwork seeking to have the state case thrown out on double jeopardy grounds. That trial is scheduled to begin next month, but could be pushed back or canceled altogether depending on what the judge decides.
If it succeeds, Mangione’s defense team could concentrate on trying to convince the judge in his federal case, Margaret Garnett, to spare him from the life sentence that prosecutors say they intend to seek when he’s sentenced on Dec. 18.
In their double jeopardy filing Friday, Mangione’s lawyers described him as a “pawn in parallel prosecutions," and defense lawyer Karen Friedman Agnifilo accused state and federal prosecutors of “trying to punish him twice for the exact conduct.”
Indeed, Mangione remains scheduled to go to trial on state murder charges beginning Sept. 8. His federal trial — now moot because of his guilty plea — was set for January.
Complicating matters, anything said in federal court — including Mangione's statements Friday admitting to killing Thompson — potentially could be used against him in state court, or vice versa.
But that's not all. Prosecutors say they have a trove of evidence that proves Mangione’s guilt, including: Video of him shooting Thompson and tailing him the day before; Mangione’s DNA and fingerprints on items at or near the crime scene; testimony from shooting witnesses; a 3D-printed 9mm pistol that police found in his backpack when he was arrested that authorities said matched the gun used to kill Thompson; and a notebook found with Mangione at the time of his arrest in which he expressed a willingness to kill a healthcare executive.
The defense previously argued all the items in Mangione's backpack were obtained in an unconstitutional search, but judges in both the federal and state cases disagreed.
Mangione's guilty plea, just three weeks before jury selection in his state murder trial, appeared to be part of a larger defense strategy to swiftly resolve both cases, minimize his legal consequences and, perhaps, give him a chance to live some of his life outside a prison cell. Earlier plea talks broke down in June.
Within minutes of his plea, Mangione’s lawyers petitioned the judge in the state case, Gregory Carro, to throw out those charges on double jeopardy grounds. Instead of two trials — and two potential sentences that could run back-to-back — they are fighting for just one and are sure to argue he deserves a far lesser sentence than life in prison.
Manhattan District Attorney Alvin Bragg's office, which is prosecuting the state case, will have a chance to respond to the defense's double jeopardy motion before Carro rules. In a statement, the office said it would fight efforts to terminate the state case, in part because Mangione's sentence in the federal case isn't yet known. Thompson's family members, in a statement, suggested they are also looking forward to the state case going to trial. Mangione has pleaded not guilty in the state case.
Compared with federal law and that of other states, New York has uncommonly strong protections for defendants facing multiple prosecutions — though they are not guaranteed.
Bragg's office contends that the state charges, including murder and firearms offenses, involve different legal elements and criminal conduct than federal charges, which alleged Mangione traveled across state lines to stalk and kill Thompson.
However Carro rules, his decision will be subject to appeal, meaning a final answer on whether Mangione faces a state trial could take a while.
Mangione’s lawyers previously fended off the government’s attempts to seek the death penalty. Now they're fighting for a sentence that's less than the life term U.S. Attorney Jamie McDonald said federal prosecutors intend to seek. Life is also the maximum punishment in Mangione's state case.
Unlike other defendants, Mangione doesn't have a plea deal with prosecutors. There were “no accommodations or concessions, and we are free to seek the maximum penalty under the law," McDonald said.
Still, Garnett noted in court that the government’s calculation of federal sentencing guidelines would call for a sentence of 24 to 30 years in prison. Mangione's lawyers can submit their own calculation and both sides can argue for greater or lesser punishment in submissions to the judge. Such filings typically chronicle the impact of a defendant's crimes, as well as his history, upbringing and other aggravating or mitigating factors.
Mangione will also be interviewed by probation officers, Garnett said, adding that the report they produce will factor heavily in her sentencing decision. Judges are free to ignore sentencing guidelines, which are intended to reduce disparities in punishments levied for the same crimes.
Garnett told Mangione she is obliged to determine what she thinks is the correct guideline range and “more importantly what I think the appropriate sentence is in your case.”
“No one, not your lawyers, not the government’s lawyers, no one can give you any assurance of what your sentence will be since I am the one who will decide your sentence,” the judge said, “and I’m not going to do that today.”
FILE - Luigi Mangione, a suspect in the fatal shooting of UnitedHealthcare CEO Brian Thompson, is escorted by police, Thursday, Dec. 19, 2024, in New York. (AP Photo/Pamela Smith, File)
In this courtroom sketch, Luigi Mangione, center, stands between his attorneys, Karen Friedman Agnifilo, left, and Marc Agnifilo, right, as he is sworn in before pleading guilty to federal stalking charges in the killing of UnitedHealthcare CEO Brian Thompson, Friday, Aug. 14, 2026, in New York. (Jane Rosenberg via AP)
Defense attorneys for Luigi Mangione, Karen Friedman Agnifilo and Marc Agnifilo exit Manhattan federal court after Mangione pleaded guilty on to federal stalking charges in the killing of UnitedHealthcare CEO Brian Thompson, Friday, Aug. 14, 2026 in New York. (AP Photo/Ryan Murphy)
Luigi Mangione appears for a pre-trial hearing at Manhattan Criminal Court in New York, on Tuesday, Aug. 11, 2026. (Steven Hirsch/New York Post via AP, Pool)
